Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets

Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets

The need for optimal treatment of the active forms of multiple sclerosis (MS), especially highly active MS (HAMS), poses a number of difficult problems for specialists, including not only the choice of a highly effective disease-modifying drug for MS (DMDMS), but also conditions for the timely and s...

Full description

Bibliographic Details
Main Authors: N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2020-10-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
highly active multiple sclerosis
disease-modifying drugs for multiple sclerosis
cladribine tablets
Online Access:https://nnp.ima-press.net/nnp/article/view/1459

Internet

https://nnp.ima-press.net/nnp/article/view/1459

Similar Items